R and D spend to slow short-term growth at Fidessa
Fidessa, the software provider focused on the financial community, reckons things will remain tough for its clients for some time, and expects some of them to leave the market altogether.
Fidessa, the software provider focused on the financial community, reckons things will remain tough for its clients for some time, and expects some of them to leave the market altogether.
Despite the challenging conditions that have persisted within the financial markets, Fidessa continued to deliver growth during the first quarter of 2012. Progress has been made across the regions, particularly with larger customers as they seek strategic partners with scale, vision and resource to support their broadening needs.
Though it expects market conditions will remain difficult for some time to come, that is not stopping Fidessa from increasing development spend, both in terms of actual product development and also in terms of investment in the infrastructure and expertise required to support new opportunities.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
As stated in the preliminary results in February 2012, as a result of this investment and the ongoing market conditions, Fidessa believes that while it can continue to deliver growth in 2012, this growth is likely to be at levels which are lower than those seen in 2011.
JH
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
Are these FTSE 100 pharmaceutical stocks worth a look?
Pharmaceutical stocks are some of the biggest in the FTSE 100. The sector is threatened by tariffs, but some have posted encouraging results regardless.
-
First-time buyer mortgages that lend a hand
The first rung of the property ladder can feel like more of a leap than a step – but choosing the right mortgage can help